Review Article
Appraisal of the current guidelines for management of cholangiocarcinoma—using the Appraisal of Guidelines Research and Evaluation II (AGREE II) Instrument
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:126-135
.
(01 April 2020)
Appraisal of the current guidelines for the management of cholangiocarcinoma using AGREE II instrument demonstrated that they are based on relatively low-quality evidence.
Preparing for liver surgery with “Alphabet Soup”: PVE, ALPPS, TAE-PVE, LVD and RL
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:136-151
.
(01 April 2020)
Future liver remnant (FLR) size and function is a critical limiting factor for treatment eligibility and postoperative prognosis when considering major hepatectomy. The article reviews the principles and applications of portal vein embolization (PVE) and the newer hepatic regenerative techniques to improve peri- and postoperative outcomes.
Review Article on Gut Microbiome and Liver Disease1
Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:152-169
.
(01 April 2020)
Original Article on Gut Microbiome and Liver Disease1
Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:170-182
.
(01 April 2020)
Original Article
Is there any correlation between liver graft regeneration and recipient’s pretransplant skeletal muscle mass?—a study in extended left lobe graft living-donor liver transplantation
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:183-194
.
(01 April 2020)
This study on living-donor liver transplantation recipients showed that pre-transplant sarcopenia was associated with an impaired early regenerative capacity of the graft. Thus, along with portal circulation and graft quality, even the pre-transplant metabolic status of the recipient is a significant determinant of graft regeneration.
Editorial
Minimally invasive surgery of malignancies: time to argue the fundamental reasons for this emerging technique
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:195-197
.
(01 April 2020)
Sarcopenia, obesity and postoperative outcomes after hepatectomy for hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:198-201
.
(01 April 2020)
Is sarcopenic obesity superior to sarcopenia as a predicting indicator in patients with hepatocellular carcinoma following hepatic resection?
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:202-204
.
(01 April 2020)
Clinical value and cost-effectiveness of minimally invasive distal pancreatectomy
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:205-207
.
(01 April 2020)
Time to take another look at perceived disadvantages of robotic hepatectomy
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:208-210
.
(01 April 2020)
Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:211-214
.
(01 April 2020)
Optimizing future remnant liver prior to major hepatectomies: increasing volume while decreasing morbidity and mortality
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:215-218
.
(01 April 2020)
Is the robot necessary for enhanced recovery after minimally invasive surgery hepatectomy?
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:219-220
.
(01 April 2020)
The role of preoperative immune modulating nutrition
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:221-222
.
(01 April 2020)
Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:223-226
.
(01 April 2020)
Risk management of hepatocellular carcinoma occurrence after hepatitis C virus eradication—from IFN based era to IFN-free DAA era
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:227-229
.
(01 April 2020)
Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis—implications for surveillance and future pharmacotherapy
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:230-234
.
(01 April 2020)
Role of image-guided percutaneous thermal ablation in the management of colorectal cancer liver metastases
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:235-238
.
(01 April 2020)
Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:239-241
.
(01 April 2020)
Synchronous colorectal liver metastases: timing of resection and patterns of referral
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:242-243
.
(01 April 2020)
Road to identifying endpoint biomarkers in the treatment of nonalcoholic steatohepatitis: are we there yet?
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:244-246
.
(01 April 2020)
Is obesity a disease?—the evolving concepts, cancer paradox and association with improved cancer immunotherapy efficacy
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:247-249
.
(01 April 2020)
Viewpoint
Organ transplantation management in the midst of the COVID-19 outbreak: a synopsis
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:250-252
.
(01 April 2020)
Weight-based dosing of lenvatinib for advanced hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:253-254
.
(01 April 2020)
Incidence of hepatocellular carcinoma after HCV eradication: assessing the risk
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:255-256
.
(01 April 2020)
Outcome of direct-acting antiviral treatment for patients with chronic hepatitis C virus infection: clinical benefit proven?
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:257-259
.
(01 April 2020)
Letter to the Editor
Intra-operative trans-cystic indocyanine green (ICG) cholangiography: a high-sensitive method to identify bile leakage after hepatic resection
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:260-262
.
(01 April 2020)
A primary hepatic neuroendocrine tumor disguised as hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:263-266
.
(01 April 2020)
Images in Clinical Medicine
Horrible hepatic portal venous gas
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:267-268
.
(01 April 2020)
Meet the Professor2
Prof. John Chabot: working hard and asking important questions, but also keeping focused
HepatoBiliary Surgery and Nutrition
2020;
9
(2)
:269-270
.
(01 April 2020)
Disclosure:
1. The series “Gut Microbiome and Liver Disease” was commissioned by the editorial office, Hepatobiliary Surgery and Nutrition without any sponsorship or funding. Yu-Jui Yvonne Wan served as the unpaid Guest Editor for the series.
2. The series “Meet the professor” was commissioned by the editorial office, Hepatobiliary Surgery and Nutrition without any sponsorship or funding.
